Tonghua Golden Horse Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") and all members of the board of directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Reminder: The total amount of guarantees provided by the listed company and its controlling subsidiaries exceeds 50% of the company's most recent audited net assets; investors should pay close attention to guarantee risks.
The 11th Board of Directors of Tonghua Golden Horse Pharmaceutical Group Co., Ltd. held its first temporary meeting on February 27, 2026, where it reviewed and approved the proposal regarding the guarantee provided by the wholly-owned subsidiary for the parent company. The specific circumstances are announced as follows:
1. Overview of the Guarantee
(1) Basic Information on the Guarantee
Due to production and operational needs, the Company intends to apply for a credit loan not exceeding RMB 55 million from Guangfa Bank Co., Ltd. Changchun Branch. The Company's wholly-owned subsidiary, Chengdu Yongkang Pharmaceutical Co., Ltd., will provide a guarantee for the aforementioned loan, with a guarantee amount not exceeding RMB 55 million in principal and corresponding interest and fees, with a guarantee period of one year.
(2) Approval of the Guarantee
The proposal regarding the guarantee provided by the wholly-owned subsidiary for the parent company was approved by the 11th Board of Directors with 9 votes in favor, 0 abstentions, and 0 votes against. According to Article 6.1.10 of the Shenzhen Stock Exchange Listing Rules, this proposal must be submitted for shareholder review.